KalVista Pharmaceuticals (KALV) Free Cash Flow (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly Free Cash Flow of -$54.6 million in Q3 2025, down 34.25% quarter-over-quarter from -$40.7 million in Q2 2025, and down 35.66% year-over-year from -$84.9 million in Q3 2024.
KalVista Pharmaceuticals' Free Cash Flow history runs 12 years deep, the most recent figure standing at -$54.6 million for Q3 2025.
- In Q3 2025, Free Cash Flow fell 35.66% year-over-year to -$54.6 million; the TTM figure through Jul 2025 stood at -$135.1 million (down 31.36% YoY), while the FY2025 annual figure was -$153.4 million, down 71.83% from the prior year.
- Free Cash Flow came in at -$54.6 million for Q3 2025 at KalVista Pharmaceuticals, down from -$40.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$7.6 million in Q1 2021 to a low of -$54.6 million in Q3 2025.
- A 5-year average of -$24.4 million and a median of -$21.7 million in 2022 frame the typical range for Free Cash Flow.
- On a YoY basis, Free Cash Flow climbed as much as 42.02% in 2021 and fell as far as 399.22% in 2021.
- KalVista Pharmaceuticals' Free Cash Flow stood at -$19.9 million in 2021, then declined by 4.45% to -$20.8 million in 2022, then gained by 4.61% to -$19.8 million in 2023, then slumped by 100.27% to -$39.7 million in 2024, then tumbled by 37.63% to -$54.6 million in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$54.6 million, -$40.7 million, and -$39.7 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | -54.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -54.65 Mn |
| Jul 31, 2025 | -54.65 Mn |
| Apr 30, 2025 | -40.71 Mn |
| Apr 30, 2025 | -40.71 Mn |
| Oct 31, 2024 | -39.71 Mn |
| Oct 31, 2024 | -39.71 Mn |
| Jul 31, 2024 | -40.28 Mn |
| Jul 31, 2024 | -40.28 Mn |
| Apr 30, 2024 | -14.85 Mn |
| Apr 30, 2024 | -14.85 Mn |
| Jan 31, 2024 | -27.86 Mn |
| Jan 31, 2024 | -27.86 Mn |
| Oct 31, 2023 | -19.83 Mn |
| Oct 31, 2023 | -19.83 Mn |
| Jul 31, 2023 | -26.74 Mn |
| Jul 31, 2023 | -26.74 Mn |
| Apr 30, 2023 | -22.71 Mn |
| Apr 30, 2023 | -22.71 Mn |
| Jan 31, 2023 | -9.30 Mn |
| Jan 31, 2023 | -9.30 Mn |
| Oct 31, 2022 | -20.79 Mn |
| Oct 31, 2022 | -20.79 Mn |
| Jul 31, 2022 | -23.66 Mn |
| Jul 31, 2022 | -23.66 Mn |
| Apr 30, 2022 | -26.88 Mn |
| Apr 30, 2022 | -26.88 Mn |
| Jan 31, 2022 | -14.27 Mn |
| Jan 31, 2022 | -14.27 Mn |
| Oct 31, 2021 | -19.90 Mn |
| Oct 31, 2021 | -19.90 Mn |
| Jul 31, 2021 | -18.02 Mn |
| Jul 31, 2021 | -18.02 Mn |
| Apr 30, 2021 | -11.08 Mn |
| Apr 30, 2021 | -11.08 Mn |
| Jan 31, 2021 | -7.60 Mn |
| Jan 31, 2021 | -7.60 Mn |
| Oct 31, 2020 | -7.97 Mn |
| Oct 31, 2020 | -7.97 Mn |
| Jul 31, 2020 | -3.61 Mn |
| Jul 31, 2020 | -3.61 Mn |
| Apr 30, 2020 | -12.63 Mn |
| Apr 30, 2020 | -12.63 Mn |
| Jan 31, 2020 | -13.11 Mn |
| Jan 31, 2020 | -13.11 Mn |
| Oct 31, 2019 | -7.93 Mn |
| Oct 31, 2019 | -7.93 Mn |
| Jul 31, 2019 | -11.37 Mn |
| Jul 31, 2019 | -11.37 Mn |
| Apr 30, 2019 | -10.79 Mn |
| Apr 30, 2019 | -10.79 Mn |
| Jan 31, 2019 | -10.88 Mn |
| Jan 31, 2019 | -10.88 Mn |
| Oct 31, 2018 | -9.01 Mn |
| Oct 31, 2018 | -9.01 Mn |
| Jul 31, 2018 | -6.78 Mn |
| Jul 31, 2018 | -6.78 Mn |
| Apr 30, 2018 | -7.04 Mn |
| Apr 30, 2018 | -7.04 Mn |
| Jan 31, 2018 | 28.04 Mn |
| Jan 31, 2018 | 28.04 Mn |
| Oct 31, 2017 | -7.31 Mn |
| Oct 31, 2017 | -7.31 Mn |
| Jul 31, 2017 | -4.56 Mn |
| Jul 31, 2017 | -4.56 Mn |
| Apr 30, 2017 | -2.65 Mn |
| Apr 30, 2017 | -2.65 Mn |
| Jan 31, 2017 | -11.25 Mn |
| Jan 31, 2017 | -11.25 Mn |
| Oct 31, 2016 | -4.20 Mn |
| Oct 31, 2016 | -4.20 Mn |
| Jul 31, 2016 | -5.70 Mn |
| Jul 31, 2016 | -5.70 Mn |
| Mar 31, 2016 | -5.27 Mn |
| Mar 31, 2016 | -5.27 Mn |
| Dec 31, 2015 | -5.45 Mn |
| Dec 31, 2015 | -5.45 Mn |
| Sep 30, 2015 | -5.33 Mn |
| Sep 30, 2015 | -5.33 Mn |
| Jun 30, 2015 | -6.52 Mn |
| Jun 30, 2015 | -6.52 Mn |
| Mar 31, 2015 | -4.23 Mn |
| Mar 31, 2015 | -4.23 Mn |
| Sep 30, 2014 | -3.23 Mn |
| Sep 30, 2014 | -3.23 Mn |
| Jun 30, 2014 | -2.01 Mn |
| Jun 30, 2014 | -2.01 Mn |
| Mar 31, 2014 | -1.76 Mn |
| Mar 31, 2014 | -1.76 Mn |